logo

Sector: Healthcare Equipment & Supplies

|

Small Cap

Nureca Share Price

NURECA

333.85

13.95(4.36%)
28th Aug 2026 | 3:09 PM
NSE : NURECA

Open Free Demat Account

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Nureca Performance

Price Movement

₹333.85

₹321.10

₹335.85

Today's LowToday's High

1 Year Performance

₹333.85

₹204.00

₹358.00

52 Week Low52 Week High

Markets Today

High₹335.85
Low₹321.10
Open at₹334.75
Prev Close₹319.90
Volumes15.00 K
Avg Price₹332.74
Lower Circuit₹303.95
Upper Circuit₹335.85

Historical Performance

3M High₹358.00
3M Low₹224.02
1 Yr High₹358.00
1 Yr Low₹204.00
3 Yr High₹468.80
3 Yr Low₹203.62
5 Yr High₹2,315.00
5 Yr Low₹203.62

Nureca Share Price Today

As of 28-08-2026 15:39, Nureca Ltd. share price today is ₹0, with a change of ₹-319.90 (-100.00%) from the previous close of ₹319.9. The stock opened at ₹334.75 and traded between ₹321.1 and ₹335.85, with a total traded volume of 14997 shares. The company has a market capitalization of ₹304.7 Cr in the Healthcare sector. while its 52-week high and low are ₹358 and ₹204, respectively.

Nureca Ltd. valuation metrics include a P/E ratio of 70.3, EPS of ₹2.11, and book value of ₹1.70. Profitability indicators show ROE of 1.15%. Nureca Ltd. has reported revenue of ₹153.13 Cr and net profit of ₹4.34 Cr.

Nureca Ltd. technical indicators include Day RSI at 46.59, Day MFI at 29.53, Day ADX at 35.96. Additional indicators include Commodity Channel Index (CCI) at -142.5 and Williams %R at -78.61. Momentum indicators show Day MACD at 3.39, Day MACD Signal Line at 10.63, DayATR at 16.66. Rate of Change indicators for Nureca Ltd. include ROC125 at 4.42 and ROC21 at -2.26.

Exponential moving averages include EMA5 at ₹306.8, EMA10 at ₹314.3, EMA12 at ₹315.8, EMA20 at ₹315.7, EMA26 at ₹312.4, EMA50 at ₹298.1, EMA100 at ₹283.8, EMA200 at ₹276.3. Simple moving averages include SMA5 at ₹305.6, SMA10 at ₹320.6, SMA20 at ₹327.8, SMA30 at ₹318.2, SMA50 at ₹286.5, SMA100 at ₹273, SMA150 at ₹272.7, SMA200 at ₹276.

Support levels for Nureca are placed at First Support ₹297.17, Second Support ₹289.63, Third Support ₹284.27. Resistance levels are seen at First Resistance ₹310.07, Second Resistance ₹315.43, Third Resistance ₹322.97. Nureca Ltd. shareholding pattern shows promoter holding at 68.09%, FII holding at 0.11%, DII holding at 0%, public holding at 31.57%.

Nureca Fundamentals

Market Cap
Above industry Median
304.70 Cr.
PE Ratio (TTM)
High in industry
70.30
Dividend Yield
0
Net Profit TTM
0% decr over last year
4.34
Net Profit Growth
0% decr over last year
4.34
PEG Ratio
Above industry Median
0
ROE
167.4% incr over last year
1.15
Operating Revenue TTM
153.13
Operating Revenue Growth
23.9% incr over last year
Book Value
Below industry Median
1.70
MFI
MFI oversold
29.53
RSI
RSI is mid-range
46.59
EPS (TTM)
2.11
Debt to Equity
0
Face Value
10
Operating Profit Margin Qtr.
0.12
Operating Profit Qtr.
3.42
Net Profit Qtr.
3.07
Operating Revenue Qtr.
40.34
PB Ratio
1.70

Nureca Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Total Revenue40.4035.4039.6437.8434.32
Operating Expense37.9541.9437.2435.2235.40
Operating Profit2.44-6.542.402.62-1.08
Depreciation0.570.430.460.480.48
Interest0.180.240.180.410.20
Tax1.190.470.820.970.28
Net Profit2.43-6.623.233.140.55

Nureca Technicals

Nureca Ltd. EMA & SMA

333.85

37.20 (12.54%)

Bullish Moving Average

7

Bearish Moving Average

9

Day EMA5 ₹306.8
Day EMA10 ₹314.3
Day EMA12 ₹315.8
Day EMA20 ₹315.7
Day EMA26 ₹312.4
Day EMA50 ₹298.1
Day EMA100 ₹283.8
Day EMA200 ₹276.3

Nureca Support and Resistance

Resistance

First Resistance₹310.07
Second Resistance₹315.43
Third Resistance₹322.97

Support

First Support₹297.17
Second Support₹289.63
Third Support₹284.27

Technical Indicators

Day RSI46.59
Day MFI29.53
Day ADX35.96
Day Commodity Channel Index-142.50
William-78.61
Day MACD3.39
Day MACD Signal Line10.63
Day ATR16.66
Day ROC1254.42
Day ROC21-2.26

About Nureca Stock Share Price

Nureca is a digital-first company operating in the home wellness sector, primarily known for its “Dr Trust” brand. The company focuses on manufacturing and selling smart medical devices such as blood pressure monitors, pulse oximeters, thermometers, and other health-related gadgets directly to consumers. Nureca leverages online platforms to reach a wide customer base, reflecting the growing trend of digital healthcare and home wellness in India. The company’s business model emphasizes e-commerce sales and direct-to-consumer distribution, which enables it to interact closely with its customers and respond to demand patterns efficiently. Tracking the Nureca share price provides insight into investor sentiment and market reaction to the company’s performance. Analysts and traders use the Nureca stock quote and share trend to assess the company’s market position and compare it to other digital health firms. Observing the Nureca live price is particularly useful for understanding the company’s short-term market behavior during online sales campaigns. The company’s revenue growth largely depends on maintaining consumer loyalty and expanding its product range. Monitoring the Nureca market cap offers a benchmark against other mid-sized digital wellness companies. Overall, Nureca represents a significant example of the intersection between healthcare technology and online retail in India. 

Nureca Fundamentals 

A. Company Background

Nureca Limited is an India‑based healthcare and wellness products company engaged in the design, development, manufacture, and marketing of home healthcare, wellness, and lifestyle products. The company was incorporated on 2 November 2016 and is listed on the National Stock Exchange of India and BSE Limited. It operates brands such as Dr Trust, Dr Physio and Trumom offering a range of medical monitoring devices, orthopedic and lifestyle products, mother & baby care items, and connected digital health solutions. Nureca also has a wholly owned subsidiary, Nureca Inc., headquartered in the United States to support its international distribution. The company has sold millions of products in India and several other countries and holds certifications and patents for many of its devices.  

 B. Company Product Lines

  • Home Healthcare & Monitoring Devices  
  • Blood pressure monitors, finger pulse oximeters, glucose meters, thermometers  
  • Connected products including ECG and fitness trackers used for health monitoring at home  
  • Dr Trust brand is the flagship range for these products  
  • Orthopedic & Pain Management Products  
  • Massagers, posture correctors, rehabilitation aids  
  • Products designed to assist pain relief and physical recovery under the Dr Physio brand  
  • Lifestyle & Personal Care Products  
  • Humidifiers, steamers, personal scales, yoga and exercise‑related products  
  • Fitness and wellness‑oriented devices  
  • Mother & Baby Care  
  • Feeding products, carry cots, skincare products, baby warmers  
  • Marketed under the Trumom brand  
  • Nutrition & Connected Health Solutions  
  • Nutritional supplements and smart ecosystems such as the Dr Trust 360 app that integrates device data for users  

 C. Company Revenue Model

  • Product Sales (Direct & Channel)  
  • Revenue primarily from the sale of healthcare and wellness devices through direct e‑commerce channels, marketplaces, retail partners and distributors  
  • Connected & Digital Services  
  • Revenue related to connected health offerings linked to app platforms and smart devices such as Dr Trust 360  
  • Brand Licensing & Partnerships  
  • Strategic brand collaborations and marketplace tie‑ups that expand product reach and customer base  
  • Export Revenue  
  • Income from global sales supported through the U.S. subsidiary and international distributors  

 D. Geographic Presence

  • Headquarters & Registered Office  
  • Mumbai, Maharashtra, India; operational presence also includes key offices such as in Chandigarh, India  
  • International Operations  
  • Wholly‑owned subsidiary Nureca Inc. in the United States supporting global distribution  
  • Market Reach  
  • Products sold across India via online and offline channels  
  • Global presence in multiple countries with customers in five countries worldwide 

E. Leadership

  • Aryan Goyal – Executive Director, Whole Time Director & Chief Executive Officer  
  • Naresh Gupta – Chief Financial Officer  
  • Chetna Anand – Company Secretary  
  • Nishu Kansal – Company Secretary  
  • Aryan Goyal – Whole Time Director & Chief Executive Officer  
  • Saurabh Goyal – Chairman & Managing Director  
  • Vijay Kumar Sharma – Independent Director  
  • Rajinder Sharma – Whole-Time Director  
  • Ruchita Agarwal – Independent Director  
  • Charu Singh – Independent Director  
  • Kuldip Kumar Bhasin – Independent Director  
  • Rupinder Tewari – Independent Director  
  • Nishu Kansal – Company Secretary & Compliance Officer 

 F. Key Milestones

  • 2016 – Nureca Limited incorporated in India.  
  • 2021 – Company listed on the National Stock Exchange of India and BSE Limited.  
  • 2024–2025 – Reported significant financial growth and expanded strategic partnerships to enhance market presence and distribution.  
  • Ongoing – Continued expansion of product range and digital health ecosystem with Dr Trust 360 app integration 

 G. Industry Perspective

The Indian preventative healthcare sector thrives on a rapidly growing middle class and increasing health consciousness post-pandemic. A deeper look at the retail wellness outlook shows a clear pivot towards branded, reliable at-home monitoring devices over cheap unbranded imports. Companies with established digital supply chains and brand recall benefit immensely from the shift away from the unorganized sector. Adapting to fast-changing e-commerce algorithms remains the biggest hurdle for digital-first firms. For astute buyers, seeing a brand maintain consumer loyalty during an economic downturn strongly influences the Nureca share price. In conclusion, the ability to navigate fast-paced online retail cycles directly impacts the Nureca stock price.

Nureca Stock Market Presence – Listing and Index Representation 

Nureca is listed on the Bombay Stock Exchange (BSE) under Scrip Code: 543264 and on the National Stock Exchange (NSE) under the symbol NURECA. Institutional investors and traders monitor the Nureca share price to evaluate sector trends, especially during high-volume e-commerce periods. The company is not included in the Nifty 50 or other broad benchmark indices but is relevant to sector-specific and mid-cap trackers focusing on consumer health and digital wellness. Index inclusion for specialized trackers provides insight into how Nureca performs relative to similar companies in the online health technology sector. Observing the Nureca live price illustrates the market’s response to quarterly sales data and other operational metrics. Daily monitoring of the Nureca stock price helps investors gauge short-term market sentiment and volatility. 

Nureca Stock Performance and Share Price History 

Nureca’s stock performance closely follows trends in India’s online retail and healthcare consumption. Historical share price charts show movements tied to marketing campaigns, product launches, and online traffic trends. The company’s price pattern reflects customer acquisition efforts and seasonal e-commerce fluctuations. Traders rely on key support and resistance levels based on quarterly sales figures to make trading decisions. Real-time price tracking and advanced charting tools are used to analyze volatility and identify trading opportunities. Monitoring the Nureca share price before executing large orders ensures accurate entry points. Retail execution and consistent product delivery directly influence the underlying stock price. Past share price trends provide a reference for understanding market behavior and investor confidence in the company’s growth strategy. 

Nureca Investor Relevance and Role in Portfolio 

Investors consider Nureca due to the increasing focus on health awareness in India. The company’s performance is closely linked to digital marketing effectiveness, logistics efficiency, and expanding offline partnerships. Investors compare Nureca’s valuation metrics, such as the P/E ratio and EPS, against similar FMCG and wellness companies to assess investment potential. A history of consistent revenue and dividend distribution makes the stock relevant for long-term holdings. Momentum traders also monitor intraday fluctuations in the Nureca share price to take advantage of short-term market movements. Evaluating these metrics allows investors to make informed decisions regarding portfolio allocation, while the company’s digital-first approach supports continuous engagement with its consumer base. 

Nureca Sectoral Relevance and Peer Positioning 

Nureca occupies a significant position in the digital home wellness sector, particularly in devices such as blood pressure monitors and pulse oximeters. The company has built a strong online presence through verified customer reviews and brand trust. Competitively, Nureca focuses on maintaining visibility on major e-commerce platforms, ensuring prime search rankings, and responding to algorithm changes on these sites. A SWOT-based evaluation shows strong brand recognition but also highlights exposure to platform-related changes. The Nureca share price is influenced by collective market sentiment, reflecting both consumer demand and competitive pressures. Compared to peers, Nureca demonstrates consistent engagement with its digital audience and stable performance within the consumer health niche. 

Summary 

Nureca is a digital-first home wellness company that sells health devices directly to consumers under the Dr Trust brand. The company’s stock is listed on both BSE and NSE and monitored by traders and institutional investors for market sentiment and sector trends. Its performance reflects India’s online retail and healthcare consumption patterns, with share price movements linked to marketing campaigns, product launches, and e-commerce traffic. Investors assess Nureca using valuation metrics, historical trends, and dividend history, while peer comparison highlights its position in the digital wellness market. Daily tracking of the Nureca share price offers insights into both short-term fluctuations and long-term investor confidence. 

 

 

Nureca Shareholding Pattern

Held ByMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter64.364.3656568.168.1
FII1.10.10.10.10.30.1
DII00000.20.3
Public34.635.634.934.931.431.6

Nureca Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day3.29 K3.29 K100.00%
Week9.44 K9.44 K100.00%
1 Month15.15 K21 K72.12%
6 Month12.56 K28.65 K43.85%

Nureca SWOT Analysis

Strengths27
Weakness3
Opportunity0
Threats0

High DVM Mid and Small Caps (subscription)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Turnaround Companies: Loss to Profit QoQ

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Companies with rising net profit margins - quarterly as well as TTM basis

Turnaround companies- loss to profit QoQ

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Negative to Positive growth in Sales and Profit with Strong Price momentum

Top Gainers

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Nureca Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
24 Feb, 20223INTERIM25 Feb, 2022Equity Share
21 Sep, 20212FINALEquity Share

Nureca Stock Comparison

Financials
Price (₹)₹64.60₹199.99₹331.80₹408₹154.64
% Change-4.93%2.65%0.73%-0.41%1.82%
Revenue TTM (₹ Cr)-₹286.96₹441.39₹301.50₹183.25
Net Profit TTM (₹ Cr)-₹30.89₹11.10₹11.20₹3.89
PE TTM14.1035.00164.3071.0024.80
1 Year Return-25.76-42.857.94-29.582.39
ROCE-13.704.947.5418.91
Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

FAQ's on NURECA

Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy